Vapotherm PE Ratio 2018-2023 | VAPO
Current and historical p/e ratio for Vapotherm (VAPO) from 2018 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Vapotherm PE ratio as of May 07, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Vapotherm PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2023-12-14 | 1.27 | 0.00 | |
| 2023-12-31 | 1.27 | $-9.90 | 0.00 |
| 2023-09-30 | 2.53 | $-14.54 | 0.00 |
| 2023-06-30 | 3.56 | $-20.00 | 0.00 |
| 2023-03-31 | 5.26 | $-30.56 | 0.00 |
| 2022-12-31 | 21.60 | $-33.92 | 0.00 |
| 2022-09-30 | 12.56 | $-33.36 | 0.00 |
| 2022-06-30 | 20.24 | $-29.68 | 0.00 |
| 2022-03-31 | 111.20 | $-22.16 | 0.00 |
| 2021-12-31 | 165.68 | $-18.40 | 0.00 |
| 2021-09-30 | 178.16 | $-18.08 | 0.00 |
| 2021-06-30 | 189.12 | $-17.84 | 0.00 |
| 2021-03-31 | 192.16 | $-15.28 | 0.00 |
| 2020-12-31 | 214.88 | $-17.36 | 0.00 |
| 2020-09-30 | 232.00 | $-16.80 | 0.00 |
| 2020-06-30 | 327.92 | $-18.08 | 0.00 |
| 2020-03-31 | 150.64 | $-21.36 | 0.00 |
| 2019-12-31 | 97.28 | $-22.16 | 0.00 |
| 2019-09-30 | 75.76 | $-28.48 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.007B | $0.069B |
| Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company provides flow vapor transfer cartridges, delivery tubes and disinfection kits. Vapotherm Inc. is based in Exeter, New Hampshire. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $184.697B | 24.18 |
| Stryker (SYK) | United States | $126.529B | 30.31 |
| Medtronic (MDT) | Ireland | $108.749B | 15.40 |
| Boston Scientific (BSX) | United States | $107.729B | 34.31 |
| EssilorLuxottica (ESLOY) | France | $100.445B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
| ResMed (RMD) | United States | $31.755B | 29.82 |
| Terumo (TRUMY) | Japan | $25.536B | 36.06 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.982B | 15.96 |
| Koninklijke Philips (PHG) | Netherlands | $24.619B | 19.07 |
| Baxter (BAX) | United States | $18.406B | 13.09 |
| Insulet (PODD) | United States | $12.904B | 67.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.899B | 0.00 |
| Demant (WILYY) | Denmark | $10.100B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.983B | 26.11 |
| BellRing Brands (BRBR) | United States | $7.654B | 35.85 |
| Lantheus Holdings (LNTH) | United States | $5.268B | 13.13 |
| Haemonetics (HAE) | United States | $4.835B | 24.73 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.086B | 12.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.472B | 16.42 |
| Envista Holdings (NVST) | United States | $3.265B | 13.48 |
| QuidelOrtho (QDEL) | United States | $2.935B | 10.65 |
| Neogen (NEOG) | United States | $2.688B | 25.85 |
| TG Therapeutics (TGTX) | United States | $2.655B | 74.70 |
| Green Thumb Industries (GTBIF) | United States | $2.552B | 80.87 |
| ICU Medical (ICUI) | United States | $2.480B | 21.89 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.253B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.862B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.704B | 49.93 |
| Verano Holdings (VRNOF) | United States | $1.704B | 0.00 |
| InMode (INMD) | Israel | $1.554B | 8.26 |
| Owens & Minor (OMI) | United States | $1.447B | 12.61 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.297B | 9.66 |
| Warby Parker (WRBY) | United States | $1.255B | 0.00 |
| AtriCure (ATRC) | United States | $1.041B | 0.00 |
| MacroGenics (MGNX) | United States | $1.004B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.960B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.843B | 0.00 |
| Evolus (EOLS) | United States | $0.840B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.679B | 14.71 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.648B | 15.24 |
| Valneva SE (VALN) | France | $0.522B | 0.00 |
| PetIQ (PETQ) | United States | $0.517B | 19.32 |
| Jin Medical (ZJYL) | China | $0.504B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
| Surmodics (SRDX) | United States | $0.454B | 28.45 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| Biote (BTMD) | United States | $0.430B | 8.24 |
| OraSure Technologies (OSUR) | United States | $0.424B | 7.01 |
| Aurora Cannabis (ACB) | Canada | $0.363B | 0.00 |
| Zynex (ZYXI) | United States | $0.348B | 47.56 |
| Cerus (CERS) | United States | $0.342B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.297B | 29.46 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.44 |
| Veru (VERU) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.211B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.174B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.172B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.171B | 0.00 |
| InterCure (INCR) | Israel | $0.147B | 24.77 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.47 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
| MariMed (MRMD) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.109B | 9.32 |
| Brainsway (BWAY) | Israel | $0.101B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.063B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.20 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |